References
- Levi F, Lucchini F, Negri E, et al. Cancer Mortality in Europe, 1990–1994, and an overview of trends from 1955 to 1994. Eur J Cancer 1999; 35:1477–1516.
- Stangi R, Altendorf-Hofmann A, Chamley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405–1410.
- Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of non respectable liver metastases from colorectal cancer. J Natl Cancer Inst 1996; 88:252–258.
- Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Metaanalysis of the published literature. Cancer 1996; 78: 1639–1645.
- Collins JM. Pharmacologic rationale for cancer treatment. Recent results. Cancer Res, 100: 140–143, 1986.
- Venook AP, Warren RS. Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Oncol Clin N Am 1996; 5: 411–427.
- Frei E III, Canellos GP. Dose: a critical factor in cancer chemotherapy . Am J Med 1980; 69: 585–594.
- Dedrik RL, Oldfield EH, Collins JM. Arterial drug infusion with extracorporeal removal: theoretic basis with particular reference to the brain. Cancer Treat Rep 1984; 68:373–380.
- Graham RA, Siddik ZK, Hohn DC. Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy. Cancer Chemother Pharmacol 1990; 26:210–214.
- Oldfield EH, Dedrick RL, Yeager RL, et al. Reduced systemic drug exposure by combining intraarterial chemotherapy with hemoperfusion of regional venous drainage. J Neurosurg 1985; 63:726–732.
- Fiorentini G, Rossi S, Dentico P et al. Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study. Anticancer Res 2004; 24 (3b): 2093–6.